Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Designates Ecstasy a “Breakthrough Therapy” for PTSD

The U.S. Food and Drug Administration’s classification of MDMA as a “breakthrough therapy” could lead to faster approval.

MDMA is better known as the party drug ecstasy. / Image: Science Mag
MDMA is better known as the party drug ecstasy. / Image: Science Mag

3,4-methlyenedioxymethamaphetamine, better known as MDMA or ecstasy, has a reputation for being a party drug, but may soon have a practical medical application thanks to a new classification from the FDA. According to an August 26th Science article, the drug was designated a “breakthrough therapy” to treat posttraumatic stress disorder (PTSD). The regulatory agency also gave the green light to two phase III studies of MDMA for PTSD funded by the Multidisciplinary Association for Psychedelic Studies (MAPS). The trials will cost roughly $25 million; if MAPS can raise the money, the trials could begin as soon as spring 2018 and finish by 2021.

A breakthrough therapy classification means there’s preliminary evidence that the drug offers substantial improvement over other options for a serious health condition. In the past five years, the FDA has granted nearly 200 drugs the status, which means they aim to help develop and review the treatments faster than others. For patients suffering from PTSD, traumatic memories are sparked from sensory triggers such as sounds or smells. “The disabling element of PTSD is the fact that when the memory tarts, the emotions completely override you and overwhelm the brain,” said David Nutt, a neuropsychopharmacologist at Imperial College London. “It’s been obvious for 40 years that these drugs are medicines. But it’s a huge step in acceptance.”

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report